Inside Kenya’s new cancer rules seeking to stop patients from running out of SHA cover mid-treatment
Cancer treatment in Kenya has long carried a double burden for patients: the devastating toll of the disease and the financial and systemic hurdles that stand between them and timely medical care. The Ministry of Health has unveiled the National Cancer Treatment Guidelines 2026, marking the first major revision of the country’s cancer treatment protocols […]
Kenya has launched its 2026 National Cancer Treatment Guidelines, the first major revision since 2019, aiming to address the financial and systemic challenges faced by cancer patients. The reforms standardize care, protect patients, and enhance access to specialized treatment, with nearly 45,000 new cases diagnosed annually. Key reforms include stricter timelines for diagnosis and treatment, linking cancer care to the Social Health Authority’s (SHA) digital oncology module, and ensuring patients receive services covered under their Ksh800,000 oncology benefit.
Health Cabinet Secretary Aden Duale highlighted the unified patient record across healthcare facilities, eliminating duplicate records and fragmented care. However, concerns remain over inflated hospital bills, unnecessary procedures, and delays in treatment approval. SHA warns facilities against practices that deplete patients' benefits, while the government urges healthcare providers to justify charges and avoid unnecessary medical procedures.
The guidelines also introduce modern cancer treatments like molecular profiling and immunotherapies, expanded paediatric protocols, and mandatory safety standards for chemotherapy, along with structured survivorship plans for post-treatment support. Despite these improvements, success depends on implementation, including access to specialists, diagnostic equipment, medicines, and functional referral systems nationwide.
Rewritten by urgent.news; may contain errors — check the original.